These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 28186577

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Vascular Dysfunction, Oxidative Stress, and Inflammation in Autosomal Dominant Polycystic Kidney Disease.
    Nowak KL, Wang W, Farmer-Bailey H, Gitomer B, Malaczewski M, Klawitter J, Jovanovich A, Chonchol M.
    Clin J Am Soc Nephrol; 2018 Oct 08; 13(10):1493-1501. PubMed ID: 30228110
    [Abstract] [Full Text] [Related]

  • 5. Arterial stiffness may predict renal and cardiovascular prognosis in autosomal-dominant polycystic kidney disease.
    Sági B, Késői I, Késői B, Vas T, Csiky B, Kovács T, Nagy J.
    Physiol Int; 2018 Jun 01; 105(2):145-156. PubMed ID: 29975128
    [Abstract] [Full Text] [Related]

  • 6. Early Markers of Cardiovascular Risk in Autosomal Dominant Polycystic Kidney Disease.
    Lai S, Mastroluca D, Matino S, Panebianco V, Vitarelli A, Capotosto L, Turinese I, Marinelli P, Rossetti M, Galani A, Baiocchi P, D'Angelo AR, Palange P.
    Kidney Blood Press Res; 2017 Jun 01; 42(6):1290-1302. PubMed ID: 29262409
    [Abstract] [Full Text] [Related]

  • 7. Markers of endothelial dysfunction and arterial stiffness in patients with early-stage autosomal dominant polycystic kidney disease: A meta-analysis.
    Bellos I, Kontzoglou K, Perrea DN.
    Int J Clin Pract; 2021 Apr 01; 75(4):e13721. PubMed ID: 32946652
    [Abstract] [Full Text] [Related]

  • 8. The Association of Fibroblast Growth Factor 23 with Arterial Stiffness and Atherosclerosis in Patients with Autosomal Dominant Polycystic Kidney Disease.
    Coban M, Inci A, Yılmaz U, Asilturk E.
    Kidney Blood Press Res; 2018 Apr 01; 43(4):1160-1173. PubMed ID: 30064143
    [Abstract] [Full Text] [Related]

  • 9. Cerebrovascular Pulsatility Index Is Reduced in Autosomal Dominant Polycystic Kidney Disease.
    Steele CN, Oh ES, Wang W, Farmer-Bailey H, Gitomer BY, Chonchol M, Nowak KL.
    Am J Nephrol; 2023 Apr 01; 54(5-6):165-174. PubMed ID: 37231790
    [Abstract] [Full Text] [Related]

  • 10. Early cardiovascular manifestations in children and adolescents with autosomal dominant polycystic kidney disease: a single center study.
    Karava V, Benzouid C, Hogan J, Dossier C, Denjean AP, Deschênes G.
    Pediatr Nephrol; 2018 Sep 01; 33(9):1513-1521. PubMed ID: 29774463
    [Abstract] [Full Text] [Related]

  • 11. Blood pressure and arterial stiffness in obese children and adolescents.
    Hvidt KN.
    Dan Med J; 2015 Mar 01; 62(3):. PubMed ID: 25748874
    [Abstract] [Full Text] [Related]

  • 12. Endothelial dysfunction and increased carotid intima-media thickness in patients with autosomal dominant polycystic kidney disease.
    Kocaman O, Oflaz H, Yekeler E, Dursun M, Erdogan D, Demirel S, Alisir S, Turgut F, Mercanoglu F, Ecder T.
    Am J Kidney Dis; 2004 May 01; 43(5):854-60. PubMed ID: 15112176
    [Abstract] [Full Text] [Related]

  • 13. Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease.
    Ecder T, Schrier RW.
    Nat Rev Nephrol; 2009 Apr 01; 5(4):221-8. PubMed ID: 19322187
    [Abstract] [Full Text] [Related]

  • 14. Pulse wave reflection is amplified in normotensive patients with autosomal-dominant polycystic kidney disease and normal renal function.
    Borresen ML, Wang D, Strandgaard S.
    Am J Nephrol; 2007 Apr 01; 27(3):240-6. PubMed ID: 17389784
    [Abstract] [Full Text] [Related]

  • 15. Curcumin therapy to treat vascular dysfunction in children and young adults with autosomal dominant polycystic kidney disease: Design and baseline characteristics of participants.
    Nowak KL, Farmer-Bailey H, Cadnapaphornchai MA, You Z, George D, Wang W, Jovanovich A, Soranno DE, Gitomer B, Chonchol M.
    Contemp Clin Trials Commun; 2020 Sep 01; 19():100635. PubMed ID: 33294724
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Central blood pressure and measures of early vascular disease in children with ADPKD.
    Marlais M, Rajalingam S, Gu H, Savis A, Sinha MD, Winyard PJ.
    Pediatr Nephrol; 2019 Oct 01; 34(10):1791-1797. PubMed ID: 31243534
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Regional arterial stiffness in central and peripheral arteries is differentially related to endothelial dysfunction assessed by brachial flow-mediated dilation in metabolic syndrome.
    Badhwar S, Chandran DS, Jaryal AK, Narang R, Deepak KK.
    Diab Vasc Dis Res; 2018 Mar 01; 15(2):106-113. PubMed ID: 29283006
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.